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Case RepoRt
Abstract
As a result of higher distributed consanguinity in the Mediterranean region and 
the Middle East, autosomal-recessive forms of Charcot-Marie-Tooth (ARCMT) 
are more common in these areas. CMT disease caused by mutations in the 
ganglioside-induced differentiation-associated protein 1 (GDAP1) gene is a 
severe autosomal recessive neuropathy resulting in either demyelinating CMT4A 
neuropathy or axonal neuropathy with vocal cord paresis. The patient was an 
8-year-old boy with AR inheritance that showed some delayed achievement of 
motor milestones, including walking, also bilateral foot drop, wasting of distal 
muscles in the legs, pes cavus and marked weakness of the foot dorsiflexors. He 
had no hoarseness or vocal cord paralysis. Total genomic DNA was extracted 
from whole peripheral blood of the patient and his family by using standard 
procedures. PCR- sequencing method were used to analysis the whole coding 
regions of the GDAP1 gene. A novel homozygote insertion of T nucleotide 
in codon 34 was detected (c.100_101insT) that probably led to an early stop 
codon. This mutation may be associated with a common haplotype, suggesting 
a common ancestor that needs further investigation in the Iranian population. 
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Introduction
Charcot-Marie-Tooth (CMT) is one of the sensory and motor neuropathies and 
the most common type of hereditary neuropathy (1). CMT disease is a genetically 
and clinically heterogeneous disease in which genotype-phenotype correlations 
are difficult to diagnosis. Both phenotypic features and disease severity can 
either be consistent or vary widely both within and among families. Typical 
symptoms include distal muscle weakness and loss of muscle bulk which are 
seen together with mild to moderate sensory loss, decreased or no deep tendon 
reflexes, high-arched feet and skeletal deformities such as pes cavus (2). The 
CMT hereditary neuropathies are classified based on the inheritance mode, 
causative gene or chromosomal location. CMT is classified into two CMT1 
(demyelinating form) as autosomal-dominant inherited with severely reduced 
nerve conduction velocities (NCVs) and CMT2 (axonal form) (3). The CMTX 
form is when patients have an X-linked inheritance pattern and CMT4 in case 
the pattern of inheritance is autosomal recessive (4). A number of demyelinating 
autosomal-recessive CMT (ARCMT) disorder have been associated to some 
genes including: GDAP1, EGR2, KIAA1985, MTMR2, MTMR13, NDRG1, 
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dorsiflexors developed gradually. The muscular atrophy 
showed fast progression and walking was possible only 
with external support. He had no hoarseness or vocal 
cord paralysis. Upper extremity symptoms began later 
with muscle wasting and finger contractions (mild 
claw hand deformity). As the disease progressed, the 
distal upper extremities also became severely affected 
and proximal muscles became weak too. The patient 
had been wheelchair bound at the age of 8 years old. 
Speech, hearing, vision and intelligence were intact. 
Deep tendon reflexes were abolished. The latest electro-
diagnostic study performed at 8 years of age showed 
marked slowing of nerve conduction velocity (NCV) 
(median NCV was 25 m/s) and sensory NCV – H and 
F waves – was not obtained. The CMAP amplitude was 
1MV. The electrophysiological study was compatible 
to mainly demyelinating polyneuropathy.  
Electrodiagnostic Testing
Regarding the pattern of inheritance and the 
electrodiagnostic finding (mixed type demyelinating 
and axonal) a CMT type 4A was suspected in this child 
so he was investigated for mutation in GDAP1 gene 
(the commonest autosomal recessive type of CMT4).
DNA Extraction 
Peripheral whole blood samples were extracted from 
the patient and his family by salting out method to 
isolate total genomic DNA (11). 
Mutation Analysis of the PMP22 and Cx32 gene
The patient was tested for PMP22 duplication (PMP22) 
and connexin 32 gene (Cx32), but both tests were 
negative. 
Sequencing of the GDAP1 gene
PCR amplification and direct sequencing methods 
were used for the detection of mutations in whole 
coding regions of the GDAP1 gene. Overall, a novel 
insertion in the first exon of the GDAP1 gene in one 
of the Iranian families (c: 34 insT) were detected in a 
proband patient (Fig2).
Discussion
These disorders show a wide phenotypic and genetic 
heterogeneity. A novel mutation (c.100_101insT) in 
the GDAP1 gene in an Iranian patient was identified. 
The patient showed normal motor milestones before 
the first year of age followed by early development of 
PRX, FIG4, GD4, and CTDP. In communities with 
a high percentage of consanguineous marriages, 
ARCMT is likely to account for 30-50% of all CMT 
cases (5). We should point to the fact that patients 
in the Mediterranean region and the Middle East 
with autosomal-recessive disease are usually noticed 
as isolated cases due to the insignificant size of the 
sibships. ARCMT forms are usually characterized by 
an earlier onset and a more severe disease course and 
may be demyelinating, axonal or even intermediate as 
in dominant forms. Predominantly in inbred families 
generating from the Middle East several genes have 
been identified. All mutations (nonsense, frameshift 
and deletions) in CMT disorder certainly cause loss 
of gene function. Primary peripheral demyelinating 
neuropathy is characterized by demyelination with 
severely reduced motor nerve conduction velocity 
(MNCV) cause to a partial or complete loss of the 
myelin sheath. In CMT4 and CMT1 a slow nerve 
conduction, which is lower than the 38 m/sec normal 
minimal threshold–usually 10 to 30 meters per second–
is seen. Nerve biopsy is a great diagnostic value in 
case of a demyelinating process (CMT4 subtypes). 
CMT4 with GDAP1 mutation is associated with a 
severe phenotype described by a rapidly progressive 
weakness due to inability to walk (6) that begins at 
the age of less than 3 years and is frequently due to 
recessive demyelinating intermediate and/ or axonal 
forms of CMT (7-9) with a median MNCV of 27-35 
m/s. CMT4A neuropathy or axonal neuropathy with 
vocal cord paresis which maps to the CMT4A locus 
on chromosome 8q21.1 and has six exons with 4.1 kb 
transcript encoding an ORF of 358 amino acids (7, 8, 
10). 
Case presentation
The patient was an 8-year-old Iranian boy that had a 
pedigree compatible with AR inheritance (Fig 1) (the 
patient was symptomatic at the first age). He showed 
some delayed achievement of motor milestones, 
including walking (independent walking was achieved 
at 20 months of age). The onset of the disease occurred 
in late infancy (around 18th month ages) with impaired 
walking. Bilateral foot drop, wasting of distal muscles 
in the legs, pes cavus and marked weakness of the feet 
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induce mitochondrial fragmentation without apoptosis 
mechanism (16). The first mutation in GDAP1 gene 
was found in the Mediterranean region (7, 8, 12, 18, 
19). The 7 published GDAP1 frameshift mutations are 
listed in Table 1 (8, 9, 15, 20-22). 
Here we report an Iranian patient with homozygote 
insertion in exon 1 (c.100_101insT) which is predicted 
to create an early stop codon interrupting the protein 
at codon 46. His parents were heterozygote in this 
position. This insertion was not reported previously 
and was not found in our control. 
The N terminal part of the GDAP1 protein containing 
GST-N and GST-C domains is oriented toward the 
cytosol (16). Studies of GDAP1 point mutation in 
highly conserved amino acids of the GST-N domain 
(Y29A, S34A, S36A, S37A and F68S) demonstrate a 
close relation between GDAP1-induced mitochondrial 
fission and its GSH conjugation activity. In all of 
these point mutations, especially in S34A mutation, 
increasing the number of mitochondrial aggregates 
that accumulated in perinuclear regions was seen (23). 
Because novel mutation in the GST-N domain as a 
frameshift (c.100_101insT) may be associated with a 
common haplotype, suggesting a common ancestor that 
needs further investigation in the Iranian population.
Acknowledgments
We would like to thank the patients and their families 
for their invaluable participation.
severe foot deformity at the age of 4 years.
This mutation showed an early onset of the disease and 
a progression of muscular atrophy leading to loss of 
ambulation within the first decade. Involvement of the 
upper extremities (small hand muscles) was evident at 
the end of the first decade. c.100_101insT mutation was 
not associated with vocal cord involvement as Birouk 
et al. has reported in Q163X variant (12). 
Mutation in GDAP1 gene may weaken the correct 
catalyzing S conjugation of reduced glutathione leading 
to progressive attrition of the axon and/or schwann 
cell and mutations in this gene causes demyelinating, 
intermediate or axonal forms of peripheral neuropathy 
in CMT disorder without severe CNS phenotype 
(13). GDAP1 mutations with autosomal recessive 
inheritance are associated with a rapidly progressing 
weakness that is occurred before the age of 3 years and 
the patient is not able to walk by the second or third 
decade of life (6). The demyelinating form of CMT 
disorder leads to reduced motor and sensory NCV and 
weakness and atrophy of the foot and hands, but in the 
patient with axonal CMT phenotype it is characterized 
by vocal cord paresis, hoarse voice and no change in 
NCV (14, 15). Traditional CMT classification cannot 
separate the forms of demyelinating, intermediate 
or axonal together and it depends on the clinical 
features of the patients. Recent studies have shown 
that GDAP1 is located on the outer mitochondrial 
membrane (16,17) and it is possible for GDAP1 protein 
to regulate in mitochondrial network dynamics and 
A Novel Mutation of GDAP1 Associated with Charcot-Marie-Tooth  Disease in An Iranian Family 
Fig 1. Pedigrees with a proven autosomal-recessive form of Charcot-Marie-Tooth (CMT4A)
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Fig 2. Novel T nucleotide insertion (C: 34) in the first exon of GDAP1 gene
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